4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001635088-26-000137
President & Immunovant CEO sold 187,943 shares at an average $40.53 ($7,617,074)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X06/wk-form4_1794528016.xml…